Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Apr;65(4):401-403.
doi: 10.1002/uog.29207.

Time to reconcile the dichotomy of the cardiovascular-placental axis

Affiliations
Editorial

Time to reconcile the dichotomy of the cardiovascular-placental axis

P I Cavoretto et al. Ultrasound Obstet Gynecol. 2025 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Nan MN, Garrido‐Giménez C, Garcia‐Osuna A, et al. N‐terminal pro B‐type natriuretic peptide as biomarker to predict pre‐eclampsia and maternal–fetal complications. Ultrasound Obstet Gynecol. 2025;65(4):447‐455.
    1. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992‐1005.
    1. Zeisler H, Llurba E, Chantraine F, et al. Predictive value of the sFlt‐1: PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374(1):13‐22.
    1. Stepan H, Galindo A, Hund M, et al. Clinical utility of sFlt‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction. Ultrasound Obstet Gynecol. 2023;61(2):168‐180.
    1. Lafuente‐Ganuza P, Carretero F, Lequerica‐Fernández P, et al. NT‐proBNP levels in preeclampsia, intrauterine growth restriction as well as in the prediction on an imminent delivery. Clin Chem Lab Med. 2021;59(6):1077‐1085.

LinkOut - more resources